28.48
3.67%
0.9854
Overview
News
Price History
Option Chain
Financials
Why SLP Down?
Discussions
Forecast
Stock Split
Dividend History
Simulations Plus Inc stock is traded at $28.48, with a volume of 74,960.
It is up +3.67% in the last 24 hours and down -5.69% over the past month.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. It generates maximum revenue from the software segment.
See More
Previous Close:
$27.49
Open:
$27.38
24h Volume:
74,960
Relative Volume:
0.47
Market Cap:
$565.29M
Revenue:
$66.98M
Net Income/Loss:
$9.65M
P/E Ratio:
56.95
EPS:
0.5
Net Cash Flow:
$10.19M
1W Performance:
-4.20%
1M Performance:
-5.69%
6M Performance:
-38.97%
1Y Performance:
-21.90%
Simulations Plus Inc Stock (SLP) Company Profile
Name
Simulations Plus Inc
Sector
Industry
Phone
661-723-7723
Address
42505 10TH STREET WEST, LANCASTER, CA
Simulations Plus Inc Stock (SLP) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
May-09-23 | Initiated | BTIG Research | Buy |
Oct-26-21 | Upgrade | Craig Hallum | Hold → Buy |
Jan-12-21 | Downgrade | Craig Hallum | Buy → Hold |
Oct-16-20 | Initiated | Raymond James | Outperform |
Sep-08-20 | Initiated | Oppenheimer | Outperform |
Jan-06-20 | Initiated | Craig Hallum | Buy |
View All
Simulations Plus Inc Stock (SLP) Latest News
Insider Selling: Simulations Plus, Inc. (NASDAQ:SLP) Director Sells 20,000 Shares of Stock - MarketBeat
Simulations Plus director Walter Woltosz sells $553,200 in stock - Investing.com
Simulations Plus director Walter Woltosz sells $553,200 in stock By Investing.com - Investing.com UK
Simulations Plus (NASDAQ:SLP) Stock Rating Lowered by StockNews.com - MarketBeat
Conestoga Capital Advisors LLC Trims Stock Position in Simulations Plus, Inc. (NASDAQ:SLP) - MarketBeat
Simulations Plus secures FDA grant for drug testing tech By Investing.com - Investing.com Canada
Simulations Plus (NASDAQ:SLP) Sets New 12-Month LowTime to Sell? - MarketBeat
Simulations Plus stock hits 52-week low at $29.32 amid market shifts - Investing.com
Simulations Plus secures FDA grant for drug testing tech - Investing.com
Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations - The Bakersfield Californian
Biosimulation Market is expected to Double Its Size by Upcoming - openPR
Tributary Capital Management LLC Buys 115,122 Shares of Simulations Plus, Inc. (NASDAQ:SLP) - MarketBeat
Brokers Offer Predictions for SLP Q2 Earnings - MarketBeat
Q2 Earnings Forecast for SLP Issued By William Blair - Defense World
Simulations Plus, Inc. (NASDAQ:SLP) Receives $56.00 Consensus Price Target from Analysts - Defense World
Simulations Plus' Q4 Earnings Top Estimates on Solid Revenue Growth - MSN
Simulations Plus (NASDAQ:SLP) Posts Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat
Simulations Plus Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Simulations Plus's SWOT analysis: biosimulation leader faces valuation hurdles - Investing.com India
BTIG cuts Simulations Plus stock price target By Investing.com - Investing.com Australia
Simulations Plus (SLP) Buys Pro-ficiency Holdings for $100M - MSN
Simulations Plus (NASDAQ:SLP) Receives "Outperform" Rating from William Blair - MarketBeat
Simulations Plus's SWOT analysis: biosimulation leader faces valuation hurdles By Investing.com - Investing.com UK
How To Trade (SLP) - Stock Traders Daily
Simulations Plus (NASDAQ:SLP) Sees Strong Trading VolumeHere's What Happened - MarketBeat
Simulations Plus (NASDAQ:SLP) Price Target Cut to $50.00 by Analysts at BTIG Research - MarketBeat
Simulations Plus, Inc. (NASDAQ:SLP) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Simulations Plus, Inc. (NASDAQ:SLP) Q4 2024 Earnings Call Transcript - Insider Monkey
BTIG cuts Simulations Plus stock price target - Investing.com
Simulations Plus price target lowered to $50 from $60 at BTIG - Nasdaq
Earnings call: Simulations Plus reports robust FY 2024 results, optimistic FY 2025 - Investing.com
Simulations Plus Inc (SLP) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market ... - Yahoo Finance
Simulations Plus Inc (SLP) Q4 2024 Earnings Call Highlights: Str - GuruFocus.com
Simulations Plus: Fiscal Q4 Earnings Snapshot - mySA
Simulations Plus Reports Fourth Quarter and Fiscal 2024 Financial Results - BioSpace
Simulations Plus (SLP) Surpasses Q4 Earnings Estimates - Yahoo Finance
Simulations Plus (NASDAQ:SLP) Updates FY 2025 Earnings Guidance - MarketBeat
Simulations Plus Reports 18% Revenue Increase for 2024 - TipRanks
Simulations Plus sees FY25 adjusted EPS $1.07-$1.20, consensus 63c - Nasdaq
What to Expect from Simulations Plus's Earnings - Benzinga
In A Strategic Move, John Anthony DiBella Acquires Simulations Plus Stock Options: Enhancing Value - Benzinga
Capitalizing In Growth Prospects, Daniel Szot Acquires In Simulations Plus Stock Options - Benzinga
Daniel Szot Backs Up Beliefs With A Notable Acquisition In Simulations Plus Stock Options - Benzinga
Strategic Move: Jill Fiedler-Kelly Enhances Portfolio With Simulations Plus Stock Options - Benzinga
Capitalizing In Growth Prospects, Shawn O'Connor Acquires In Simulations Plus Stock Options - Benzinga
Simulations Plus (SLP) Fell Due to EBITDA Below Expectations - Insider Monkey
Simulations Plus (SLP) Set to Announce Earnings on Wednesday - MarketBeat
Simulations Plus, Inc. (NASDAQ:SLP) Short Interest Update - MarketBeat
Simulations Plus Inc Stock (SLP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Simulations Plus Inc Stock (SLP) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
WOLTOSZ WALTER S | Director |
Oct 01 '24 |
Sale |
31.26 |
20,000 |
625,200 |
3,481,592 |
WEINER DANIEL L | Director |
Sep 27 '24 |
Sale |
31.54 |
750 |
23,655 |
6,994 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):